Phreesia, Inc. (NYSE:PHR) Shares Purchased by Millennium Management LLC

Millennium Management LLC boosted its stake in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 83.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 653,634 shares of the company's stock after acquiring an additional 296,863 shares during the quarter. Millennium Management LLC owned 1.12% of Phreesia worth $16,445,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of PHR. Barclays PLC raised its position in Phreesia by 83.6% during the third quarter. Barclays PLC now owns 94,929 shares of the company's stock valued at $2,163,000 after acquiring an additional 43,225 shares in the last quarter. Wesbanco Bank Inc. grew its holdings in Phreesia by 76.9% in the fourth quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company's stock valued at $1,157,000 after purchasing an additional 20,000 shares during the period. R Squared Ltd acquired a new stake in Phreesia in the fourth quarter valued at approximately $30,000. Rhumbline Advisers grew its holdings in Phreesia by 7.4% in the fourth quarter. Rhumbline Advisers now owns 83,631 shares of the company's stock valued at $2,104,000 after purchasing an additional 5,756 shares during the period. Finally, Venturi Wealth Management LLC acquired a new stake in Phreesia in the fourth quarter valued at approximately $76,000. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, General Counsel Allison C. Hoffman sold 3,496 shares of the company's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $25.32, for a total value of $88,518.72. Following the transaction, the general counsel now directly owns 139,134 shares in the company, valued at approximately $3,522,872.88. This represents a 2.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Balaji Gandhi sold 1,827 shares of the company's stock in a transaction that occurred on Wednesday, March 26th. The shares were sold at an average price of $27.46, for a total value of $50,169.42. Following the completion of the transaction, the chief financial officer now owns 103,591 shares in the company, valued at $2,844,608.86. This represents a 1.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 42,474 shares of company stock valued at $1,023,208. 5.80% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have commented on the company. Piper Sandler reissued an "overweight" rating and issued a $33.00 price objective (up from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. DA Davidson dropped their price objective on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a report on Monday, April 14th. KeyCorp lowered their price target on Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Canaccord Genuity Group lifted their price target on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research note on Thursday, March 13th. Finally, Wall Street Zen lowered Phreesia from a "buy" rating to a "hold" rating in a research note on Saturday. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, Phreesia currently has an average rating of "Moderate Buy" and a consensus target price of $31.33.

Phreesia Trading Up 3.4%

NYSE PHR traded up $0.82 on Tuesday, reaching $24.88. 1,015,983 shares of the company were exchanged, compared to its average volume of 441,413. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The business's fifty day moving average price is $25.03 and its 200 day moving average price is $25.23. The stock has a market capitalization of $1.48 billion, a P/E ratio of -16.93 and a beta of 0.74. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.